Home > Insider Trading > Filing (0000950170-25-023409)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1774857	Aardvark Therapeutics Inc.	AARD	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1487815	Xiangmin Cui	Ugland House, Po Box 309 Grand Cayman E9 KY1-1104	No	No	No	No
1834150	Decheng Capital Global Life Sciences Fund Iv, L.p.	Ugland House, Po Box 309 Grand Cayman E9 KY1-1104	No	No	No	No
1843384	Decheng Capital Management Iv (Cayman), Llc	Ugland House, Po Box 309 Grand Cayman E9 KY1-1104	No	No	No	No
1949026	Decheng Capital Global Healthcare Fund (Master), Lp	Ugland House, Po Box 309 Grand Cayman E9 KY1-1104	No	No	No	No
1949027	Decheng Capital Global Healthcare Gp, Llc	Ugland House, Po Box 309 Grand Cayman E9 KY1-1104	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-02-14	2,333,887	$0.00	2,333,887	No	4	C	Indirect	By Decheng Capital Global Life Sciences Fund IV, L.P.
Common Stock	Acquisiton	2025-02-14	333,412	$0.00	333,412	No	4	C	Indirect	By Decheng Capital Global Healthcare Fund (Master), LP
Common Stock	Acquisiton	2025-02-14	625,000	$16.00	2,958,887	No	4	P	Indirect	By Decheng Capital Global Life Sciences Fund IV, L.P.
Common Stock	Acquisiton	2025-02-14	625,000	$16.00	958,412	No	4	P	Indirect	By Decheng Capital Global Healthcare Fund (Master), LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Decheng Capital Global Life Sciences Fund IV, L.P.
No	4	C	Indirect	By Decheng Capital Global Healthcare Fund (Master), LP
No	4	P	Indirect	By Decheng Capital Global Life Sciences Fund IV, L.P.
No	4	P	Indirect	By Decheng Capital Global Healthcare Fund (Master), LP

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Convertible Preferred Stock	Disposition	2025-02-14	19,777,363	$0.00	2,333,887	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2025-02-14	2,825,337	$0.00	333,412	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the "Issuer") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date.
These securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. ("Fund IV"). Decheng Capital Management IV (Cayman), LLC ("GP IV") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.
These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP ("Healthcare"). Decheng Capital Global Healthcare GP, LLC ("Healthcare GP") is the general partner of Healthcare. Xiangmin Cui is the indirect managing member and ultimate beneficial owner of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.